Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 59-64

  Gozar, Mary Margaret G ^a   Price, Virginia L ^b   Kaslow, David C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CHIMERIC PROTEIN; EPITOPE; FREUND ADJUVANT; HYBRID PROTEIN; IMMUNOGLOBULIN G; MALARIA VACCINE; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOPHELES; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OOCYST; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031965098     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.59-64.1998     Document Type: Article

References (20)

1. Barr, P. J., K. M. Green, H. L. Gibson, I. C. Bathurst, I. A. Quakyi, and D. C. Kaslow. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174:1203-1208.
2. Bennetzen, J. L., and B. D. Hall. 1982. Codon selection in yeast. J. Biol. Chem. 257:3026-3031.
3. Carter, R., P. M. Graves, D. B. Keister, and I. A. Quakyi. 1990. Properties of epitopes of Pfs48/45, a target of transmission blocking monoclonal antibodics, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol. 12:587-603.
4. Duffy, P. E., and D. C. Kaslow. 1997. A novel malaria protein. Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-hlocking vaccines. Infect. Immun. 65:1109-1113.
5. Duffy, P. E., P. Pimenta, and D. C. Kaslow. 1943. Pgs28 belongs to a family of epidermal erowth factor-like antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 177:505-510.
6. Hui, G. S. N., A. Hashimuto, and S. P. Chang. 1992. Roles of conserved and allelie regions of the major merozoite surface protein (gpW5) in immunity against Plusmodium falciparwm. Infeet. Immun. 60:1422-1433.
7. Kaslow, D. C. 1993. Transmission-blocking immunity against malaria and other vector-borne diseases. Curr, Opin. Immunol. 5:557-565.
8. Kaslow, D. C. 1997. Transmission-blocking vaccines: uses and current status of development. Int. J. Parasitol. 27:183-189.
9. 8a. Kaslow, D.C. Unpublished observations.
10. Kaslow, D. C., and J. Shiloach. 1994. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarosc. Bio/Technology 12:494-499.
11. Kaslow, D. C., I. A. Quakyi, C. Syin, M. G. Raum, D. B. Keister, J. E. Coligan, T. F. McCutchan, and L. H. Miller. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333:74-76.
12. Kaslow, D. C., I. C. Bathurst, D. B. Keister, G. H. Campbell, S. Adams, C. L. Morris, J. S. Sullivan, P. J. Barr, and W. E. Collins. 1993. Safety, immunogenicity, and in vitro efficacy of a muramyl tripeptide-based malaria transmission-blocking vaccine in an Aotus nancymai monkey model. Vaccine Res. 2:95-103.
13. Kaslow, D. C., I. C. Bathurst, T. Lensen, T. Ponnudurai, P. J. Barr, and D. B. Keisfer. 1994. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodiun falciparum. Infect. Immun. 62:5576-5580.
14. O'Shannessy, D. J., P. J. Voorstad, and R. H. Quarks. 1987. Quantitation of glycoproteins on elcctroblots using the biotin-streptavidin complex. Anal. Biochem. 163:204-209.
15. Price, V., D. Mochizuki, C. J. March, D. Cosman, M. D. Detley, R. Klinke, W. Clevenger, S. Gillis, P. Baker, and D. Urdal. 1987. Expression, purification and characterization of recombinant murine granulocytc-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene 55:287-293.
16. Quakyi, I. A., R. Carter, J. Rener, N. Kumar, M. F. Good, and L. H. Miller. 1987. The 230-kD gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 139:4213-4217.
17. Struhl, K. 1985. Naturally occurring poly(dA-dT) sequences arc upstream promoter elements for constitutive transcription in yeast. Proc. Natl. Acad. Sci. USA 82:8419-8423.
18. Stura, E. A., A. S. Kang, R. S. Stefanko, J. C. Calvo, D. C. Kaslow, and A. C. Satterthwait. 1994. Crystallization, sequence and preliminary crystallographic data for transmission-blocking anti-malaria Fab 4B7 with cyclic peptides from the Pfs25 protein of P. falciparum. Acta Crystallogr. D50:535-542.
19. Williamson, K. C., D. B. Keister, O. Muratova. and D. C. Kaslow. 1995. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol. 75:33-42.
20. Zsebo, K. M., H.-S. Lu, J. C. Fieschko, L. Goldstein, J. Davis, K. Duker, S. V. Suggs, P.-H. Lai, and G. A. Bitter. 1986. Protein secretion from Saccharomyces cerevisiae directed by the prepro-α-factor leader region. J. Biol. Chem. 261:5858-5865.